Clinical pharmacokinetics and metabolism of paclitaxel after a three-hour infusion: comparison of two preparations
The clinical pharmacokinetics (PHK) of paclitaxel (PACLI) and its hydroxylated metabolites after three hours IV infusion (200 mg/m2) of two preparations were investigated in 13 patients receiving chemotherapy against breast cancer. Standard TaxolÒ was purchased from Bristol Myers Squibb and a test p...
Gespeichert in:
Veröffentlicht in: | Journal of oncology pharmacy practice 2003-12, Vol.9 (4), p.129-139 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!